Cancer Cachexia Market Report by Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others), Mode of Action (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel (Hospital Stores, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
The global cancer cachexia market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.
Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative protein balance, loss of appetite and muscle atrophy. It is caused due to the occurrence of various chronic diseases, including tuberculosis (TB), multiple sclerosis, chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus (HIV). Cancer cachexia can be treated with the utilization of various therapeutics, such as progestogen, corticosteroid, and combination therapy. Amongst these, a progestogen is a synthetic or natural steroid hormone that improves appetite and promotes weight gain, whereas corticosteroid assists in mitigating inflammation and suppressing overactive immune systems.
Cancer Cachexia Market Trends:
The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor. In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth. Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth. Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer cachexia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutics, mode of action and distribution channel.
Breakup by Therapeutics:
Progestogens
Corticosteroids
Combination Therapy
Others
Breakup by Mode of Action:
Appetite Stimulators
Weight Loss Stabilizers
Breakup by Distribution Channel:
Hospital Stores
Retail Pharmacy
Online Pharmacy
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.
Key Questions Answered in This Report
1. What was the size of the global cancer cachexia market in 2023?
2. What is the expected growth rate of the global cancer cachexia market during 2024-2032?
3. What are the key factors driving the global cancer cachexia market?
4. What has been the impact of COVID-19 on the global cancer cachexia market?
5. What is the breakup of the global cancer cachexia market based on the therapeutics?
6. What is the breakup of the global cancer cachexia market based on the mode of action?
7. What are the key regions in the global cancer cachexia market?
8. Who are the key players/companies in the global cancer cachexia market?
Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative protein balance, loss of appetite and muscle atrophy. It is caused due to the occurrence of various chronic diseases, including tuberculosis (TB), multiple sclerosis, chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus (HIV). Cancer cachexia can be treated with the utilization of various therapeutics, such as progestogen, corticosteroid, and combination therapy. Amongst these, a progestogen is a synthetic or natural steroid hormone that improves appetite and promotes weight gain, whereas corticosteroid assists in mitigating inflammation and suppressing overactive immune systems.
Cancer Cachexia Market Trends:
The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor. In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth. Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth. Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer cachexia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutics, mode of action and distribution channel.
Breakup by Therapeutics:
Progestogens
Corticosteroids
Combination Therapy
Others
Breakup by Mode of Action:
Appetite Stimulators
Weight Loss Stabilizers
Breakup by Distribution Channel:
Hospital Stores
Retail Pharmacy
Online Pharmacy
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.
Key Questions Answered in This Report
1. What was the size of the global cancer cachexia market in 2023?
2. What is the expected growth rate of the global cancer cachexia market during 2024-2032?
3. What are the key factors driving the global cancer cachexia market?
4. What has been the impact of COVID-19 on the global cancer cachexia market?
5. What is the breakup of the global cancer cachexia market based on the therapeutics?
6. What is the breakup of the global cancer cachexia market based on the mode of action?
7. What are the key regions in the global cancer cachexia market?
8. Who are the key players/companies in the global cancer cachexia market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CANCER CACHEXIA MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY THERAPEUTICS
6.1 Progestogens
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Corticosteroids
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Combination Therapy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY MODE OF ACTION
7.1 Appetite Stimulators
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Weight Loss Stabilizers
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospital Stores
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AAVogen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Actimed Therapeutics Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Aphios Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Artelo Biosciences Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 AVEO Pharmaceuticals Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Fresenius Kabi AG (Fresenius SE & Co. KGaA)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 Helsinn Healthcare SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck & Co. Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 NGM Biopharmaceuticals Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Pfizer Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Tetra Bio-Pharma
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CANCER CACHEXIA MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY THERAPEUTICS
6.1 Progestogens
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Corticosteroids
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Combination Therapy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY MODE OF ACTION
7.1 Appetite Stimulators
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Weight Loss Stabilizers
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospital Stores
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AAVogen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Actimed Therapeutics Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Aphios Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Artelo Biosciences Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 AVEO Pharmaceuticals Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Fresenius Kabi AG (Fresenius SE & Co. KGaA)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 Helsinn Healthcare SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck & Co. Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 NGM Biopharmaceuticals Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Pfizer Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Tetra Bio-Pharma
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
LIST OF TABLES
Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million US$), 2024-2032
Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million US$), 2024-2032
Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Cancer Cachexia Market: Competitive Structure
Table 7: Global: Cancer Cachexia Market: Key Players
Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million US$), 2024-2032
Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million US$), 2024-2032
Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Cancer Cachexia Market: Competitive Structure
Table 7: Global: Cancer Cachexia Market: Key Players
LIST OF FIGURES
Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2023
Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2023
Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2023
Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis
Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2023
Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2023
Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2023
Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis
